Finland· FI-REL-REL64421

Onswik

A insulins and analogues for injection, long-acting product containing insulin efsitora alfa, registered in Finland by Eli Lilly Nederland B.V. The same ATC class is registered in 5 of our 19 countries.

ATC A10AE

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedOnswikATCA10AEREGISTER NO.FI-REL-REL64421PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Insulin efsitora alfa is registered in 5 of 19 countries.

Countries holding a registration under ATC A10AE (insulins and analogues for injection, long-acting), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Insulin efsitora alfa · ATC A10AE

5 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Insulin efsitora alfa
Manufacturer
Eli Lilly Nederland B.V
Country
Finland (FI)
ATC code
A10AE
ATC class
Insulins and analogues for injection, long-acting
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Insulin efsitora alfa in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin efsitora alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Onswik
  • Liechtenstein · Onswik
  • Norway · Onswik

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdcab03a-e6f8-4848-96c1-6f6f53eb8b92
GET /v1/drugs/cdcab03a-e6f8-4848-96c1-6f6f53eb8b92?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos, esitäytetty kynä",
  "route": "Ihon alle",
  "ddd_unit": null,
  "strength": "500 U/ml",
  "atc_label": "Ylipitkävaikutteiset",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/26/2049/001",
  "fimea_rel_id": "REL64421",
  "authorised_at": "2026-08-20"
}

See everything about insulin efsitora alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.